Anthony Schwab
Internal Medicine · Columbia, SCNPI 1346814795
Payments from drug & device makers
Across 50 payments — averaging $19.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$172
- Lilly USA, LLC$110
- Novo Nordisk$86
- Integra Lifesciences Corporation$82
- AbbVie$53
- Exactech, Inc.$52
- plus $426 from 15 others
What the payments were for
- Food & beverage$981100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $172 |
| Lilly USA, LLC | 7 | $110 |
| Novo Nordisk | 5 | $86 |
| Integra Lifesciences Corporation | 2 | $82 |
| AbbVie | 3 | $53 |
| Exactech, Inc. | 1 | $52 |
| Exact Sciences | 3 | $50 |
| Pfizer | 2 | $49 |
| Novartis | 2 | $39 |
| Zimmer Biomet | 1 | $38 |
| Boehringer Ingelheim | 2 | $31 |
| Amgen | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Shield Therapeutics Inc | 2 | $29 |
| Abbott | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Medtronic | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$981 in reported general payments places this provider in the 65th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $591 |
| Atorvastatin Calcium | 34 | $202 |
| Rosuvastatin Calcium | 21 | $160 |
| Lisinopril | 31 | $142 |
| Amlodipine Besylate | 37 | $126 |
| Levothyroxine Sodium | 14 | $125 |
| Gabapentin | 11 | $72 |
| Metformin Hcl | 18 | $33 |
| Furosemide | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Columbia
- Carl MitchellColumbia$564K
- Ronald CassadaColumbia$100K
- Meer FakhryColumbia$22K
- Charles ButlerColumbia$19K
- Laura LabooneColumbia$16K
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.